Abstract
Idiopathic pulmonary arterial hypertension is a rare condition associated with significant maternal mortality. We report the management of a 37-year-old multigravida with severe disease using epoprostenol, a multidisciplinary approach, and a planned delivery. Although the patient survived the pregnancy, her pulmonary function significantly worsened. Epoprostenol, a pulmonary vasodilator, should be considered when indicated during pregnancy. Neither fetal nor neonatal harm was identified.
Original language | English |
---|---|
Pages (from-to) | 628-631 |
Number of pages | 4 |
Journal | Journal of Perinatology |
Volume | 30 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2010 |
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Obstetrics and Gynecology